Related Experiment Videos
Bone marrow sinus cell packing: a determinant of cell release
Blood
|July 1, 1975
Summary
Hypertransfusion significantly inhibits the red blood cell response to erythropoietin by affecting marrow cell release. Lowering hematocrit rapidly restores this response, highlighting its critical role.
Area of Science:
- Hematology
- Cell Biology
- Physiology
Background:
- Erythropoietin (EPO) stimulates red blood cell production.
- Hypertransfusion, or elevated hematocrit, can influence bone marrow function.
- The interaction between EPO, hematocrit, and red blood cell release is not fully understood.
Purpose of the Study:
- To investigate the effects of hypertransfusion on erythropoietin-induced reticulocytosis in mice.
- To elucidate the role of hematocrit in regulating the release of red blood cells from the bone marrow.
Main Methods:
- Ultrastructural studies of mouse bone marrow.
- Administration of erythropoietin and induction of hypertransfusion (65% hematocrit).
- Monitoring of reticulocyte response and red blood cell release.
Main Results:
- Hypertransfusion markedly inhibited erythropoietin-induced reticulocytosis.
- This inhibition was associated with reduced adventitial cell cover and reticulocyte clustering near sinuses.
- Acute reduction of hematocrit in hypertransfused, EPO-treated mice doubled the reticulocyte response.
Conclusions:
- Elevated erythropoietin may decrease the marrow-peripheral blood barrier, facilitating premature cell release.
- Hematocrit is a critical determinant of red blood cell release from the bone marrow into circulation.